Meeder Asset Management Inc Corvus Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$0.87 - $2.03 $876 - $2,044	1,007 Added 103.07%	1,984 $2,000
Q1 2022 May 10, 2022	BUY	$1.46 - $2.48 $1,426 - $2,422	977 New	977 $2,000
Q4 2021 Feb 11, 2022	SELL	$2.34 - $5.31 $1,509 - $3,424	-645 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$2.86 - $4.77 $1,844 - $3,076	645 New	645 $2,000
Q4 2020 Feb 09, 2021	SELL	$3.56 - $4.86 $2,296 - $3,134	-645 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$2.6 - $5.37 $96 - $198	37 Added 6.09%	645 $3,000
Q1 2020 May 15, 2020	SELL	$1.74 - $5.98 $2,575 - $8,850	-1,480 Reduced 70.88%	608 $1,000
Q4 2019 Feb 13, 2020	SELL	$2.56 - $5.44 $343 - $728	-134 Reduced 6.03%	2,088 $11,000
Q3 2019 Oct 17, 2019	BUY	$3.01 - $6.5 $3,660 - $7,904	1,216 Added 120.87%	2,222 $7,000
Q2 2019 Aug 05, 2019	BUY	$3.3 - $4.58 $2,346 - $3,256	711 Added 241.02%	1,006 $4,000
Q1 2019 Apr 16, 2019	SELL	$3.75 - $4.97 $3 - $4	-1 Reduced 0.34%	295 $1,000
Q4 2018 Jan 17, 2019	SELL	$3.29 - $8.94 $921 - $2,503	-280 Reduced 48.61%	296 $1,000
Q3 2018 Nov 02, 2018	BUY	$8.58 - $11.4 $4,942 - $6,566	576 New	576 $0
Q2 2018 Jul 24, 2018	SELL	$9.42 - $13.73 $1,017 - $1,482	-108 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$7.48 - $11.53 $74 - $115	10 Added 10.2%	108 $1,000
Q4 2017 Feb 02, 2018	BUY	$9.3 - $16.93 $195 - $355	21 Added 27.27%	98 $1,000
Q3 2017 Oct 20, 2017	BUY	$11.3 - $17.23 $870 - $1,326	77	77 $1,000

30.4M

1.06M

84.3K

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $223M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.